Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Anxiety
Interventions
DRUG

AZD7325

Single dose of oral solution or capsule. 3 times per subject.

DRUG

Radioligand (11C) flumazenil

Single dose of i.v solution. 4 times per subject. (3 times together with AZD7325)

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY